what are the side effects of taking bpc 157 Multifunctionality and Possible Medical Application Peptide—Literature and Patent Review Potential Side Effects of BPC-157
Description
Res Gerontol Nurs 2023;16(5):241249
621 TRPA1 antagonist ISC 17536: ISC 17536 is a potent and selective antagonist targeting TRPA1
Olivia MF, Michail S, Michael AT, Fadime D, Bindiya T, Sahin-Efe Ayse, et al
Weak acid diluents (typically 0.1% to 0.6% acetic acid) used for peptides with poor solubility in neutral aqueous solutions
It has better stability than most medications
-
